解剖性肝叶切除术治疗原发性肝癌患者对肝功能及预后的影响

doi:10.3969/j.issn.1672-5069.2017.04.036

Abstract

Lyu Yunhai, Zhang Huanchang, Shen Linjie, et al.. Application of anatomical hepatectomy in treatment of patients with primary liver cancer[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 504-506.

[1] 孙燕,屠红,陆培新,等. 肝癌家族史与肝癌关系的20年前瞻性队列研究. 中华肝脏病杂志,2014,22（10）:752-756.
[2] 汤钦猷. 肝癌治疗的“消灭与改造并举”策略. 实用肝脏病杂志,2015,18（2）：113-114.
[3] Sato S,Tanaka K,Nojiri K,et al. Hepatic resection for hepatocellular carcinoma in the elderly:Selecting hepatectomy procedures based on patient age. Anticancer Res,2015,35（12）: 6855-6860.
[4] 彭奋.解剖性与非解剖性肝叶切除术治疗晚期肝癌的安全性及临床疗效对比观察. 中华普外科手术学杂志（电子版）,2016,10（03）:238-240.
[5] 黄锦龙,王清,于勇,等. 解剖性肝切除对肝细胞癌预后的影响. 第二军医大学学报,2015,36（5）:492-499.
[6] 左玲,孟岩. 吉西他滨化疗对中晚期肝癌患者免疫功能及VEFG的影响. 海南医学院学报,2016,22（17）:2029-2031.
[7] 罗翠松,林云,曾志峰,等. 倾向值匹配法评价解剖性肝切除和非解剖性肝切除对肝细胞癌预后的影响. 第二军医大学学报, 2016,37（12）:1568-1573.
[8] Yamamoto T,Yagi S,Kita R,et al. Comparison between anatomical subsegmentectomy and nonanatomical partial resection for hepatocellular carcinoma located within a single subsegment:a single-center retrospective analysis. Hepatogastroenterology,2015,62（138）:363-367.
[9] Kim YK,Han HS,Yoon YS,et al. Total anatomical laparoscopic liver resection of segment 4（S4）,extended S4,and subsegments S4a and S4b for hepatocellular carcinoma. J Laparoendosc Adv Surg Tech A,2015,25（5）:375-379.
[10] 范应方,向飞,蔡伟,等. 三维腹腔镜Glisson鞘内血管离断法解剖性肝叶切除术的临床分析. 中华外科杂志,2016,54（3）:191-195.
[11] 彭奋.解剖性与非解剖性肝叶切除术治疗晚期肝癌的安全性及临床疗效对比观察. 中华普外科手术学杂志（电子版）,2016,10（3）:238-240.
[12] 陈超波,周铁,仇毓东,等. 精准理念指导下腹腔镜解剖性肝叶切除术肝癌. 国际外科学杂志,2014,41（8）:516-521.
[13] 伍贵祥,杨建全. 解剖性与非解剖性肝叶切除术治疗晚期肝癌的安全性以及临床疗效对比观察. 肝脏,2016,21（6）：482-484.

[1]	Zhu Yucheng, Yan Jiawei, Sun Jingkun, et al. Serum diamine oxidase level in patients with hepatitis B-induced acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2019, 22(5): 672-675.
[2]	Wang Gang, Zhao Hongbo, Zhu Yaling, et al. Cancerous XPO5 gene level in patients with hepatocellular carcinoma and its clinical significance [J]. Journal of Practical Hepatology, 2019, 22(5): 724-727.
[3]	Liu Xing, Zhao Shuli, Zhang Dianlong. Effect of sevoflurane inhalation on hepatic ischemia-reperfusion injury in patients with primary liver cancer undergoing partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(5): 728-731.
[4]	Pei Ying, Huang Feng, Yin Hongzhen, et al. Preliminary study on intestinal microecology in mice with xenograft hepatoma intervened by sodiumnorcantharidate [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 486-489.
[5]	Zhuang Taiping, Yin Yangyan, Xie Manfang, et al. Comparison of clinical features of infants with human cytomegalovirus infection and of infantile hepatitis syndrome [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 514-517.
[6]	Peng Silu, Liu Bing, Sun Hong, et al. Prognosis of patients with hepatitis B-induced acute-on-chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 545-548.
[7]	Dai Qingyun, Wang Rundong, Jia Weidong. Prediction of early tumor recurrence by predictive nutritional index in patients with hepatocellular carcinoma undergoing hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 561-564.
[8]	Cui Faqiang, Li Tao, Wang Zheng, et al. A pilot study on cetuximab and KRAS gene mutation in treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 565-568.
[9]	Yang Fucun, Shang Huaixue, Gai Yonghao. Enhanced magnetic resonance imaging by gadolinium disodium sebacate in diagnosis of patients with focal liver lesions [J]. Journal of Practical Hepatology, 2019, 22(4): 577-580.
[10]	Peng Xinjian, Xiao Yuhui, Xu Siding. Diagnostic value of diffusion-weighted magnetic resonance imaging in patients with radiation-induced liver injury with underlying hepatocelullar carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 373-376.
[11]	Zhao Xiaoguang, Shi Yujie. Protective effect of reduced glutathione on liver function in patients with advanced primary liver cancer underwent transarterial chemoembolization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 425-428.
[12]	Zhang Tingting, Wang Xuan. Clinical implications of oral glucose tolerance test in cirrhotic patients with hepatogenous diabetes [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 449-452.
[13]	Gao Pengbin, Zhao Xiaoyan, Qin Hao, Wu Fengying, Zhang Haizhen, Wang Lin, Jia Huina, Li Shujuan. Risk factors for poor prognosis of patients with hepatitis E-induced liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 220-223.
[14]	Wang Huming, Fan Dongsheng, Xu Jie, Liu Xianfegn, Zhou Ning, Li Min, Bao Nana. Cancerous miRNA-30c levels affecting the survival of patients with hepatocellular carcinoma after hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 248-251.
[15]	Li Ketian, Shen Mingge, Wang Fengrong, Hu Chunrong, Cao Yujie, Lu Peng. Impact of blood glucose levels on imaging quality of PET/CT examination in patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 256-259.

Application of anatomical hepatectomy in treatment of patients with primary liver cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments